Discussion: Current Multimodality Treatment Options in Pancreatic Cancer in Clinical Practice - What Is the Future Impact of Molecular Biological Profiling?
Visc Med
.
2022 Feb;38(1):49-55.
doi: 10.1159/000521847.
Epub 2022 Jan 21.
Authors
Alexander Kleger
1
,
Volker Ellenrieder
2
,
Helmut Friess
3
,
Patrick Michl
4
,
Martin Schneider
5
,
Yinmo Yang
6
,
Marko Kornmann
7
Affiliations
1
Clinic of Internal Medicine I, University Hospital of Ulm, Ulm, Germany.
2
Clinic of Gastroenterology, Gastrointestinal Oncology and Endocrinology, Medical University Göttingen, Göttingen, Germany.
3
Clinic of Surgery, University Hospital Rechts der Isar, TU München, Munich, Germany.
4
Clinic of Internal Medicine I, Medical University Halle (Saale), Halle (Saale), Germany.
5
Clinic of Gereral, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
6
Department of Surgery, Peking University First Hospital, Beijing, China.
7
Clinic of General and Visceral Surgery, University Hospital of Ulm, Ulm, Germany.
PMID:
35295897
PMCID:
PMC8874242
DOI:
10.1159/000521847
No abstract available